State Medicaid leaders create a plan to ensure safety, affordability, and equitable access for children and families living ...

In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical trials, key opinion leaders emphasize finding cost-effective approaches, ...

In the second part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains ...

Analysis compares care quality and efficiency within physician groups that treat Medicare Advantage patients under at-risk ...

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, ...

A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based ...

How CRO Partnerships Are Evolving to Meet Changing Industry Demands. In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech, emphasized the need for CRO ...

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply ...

2025 DIA Annual Meeting: How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials. In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer at ...

In the third part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, describes to what extent he believes artificial intelligence should be used at this ...

2025 DIA Annual Meeting: The Importance of Early Patient Feedback in Digital Endpoint Development. In an interview with Applied Clinical Trials at the 2025 DIA Annual Meeting, Brian Ongioni, chief ...